arrow
M

Maria E. Arcila

Memorial Sloan Kettering Cancer Center
H指数:105
被引数:4.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors

检测接受menin抑制剂治疗的急性白血病患者细胞外DNA中的MEN1耐药突变

2026-06-160
OAAI
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas

超声速BRAF突变检测在FNA获取的上清液游离DNA中的应用:一种评估侵袭性甲状腺癌BRAF的准确且高效的方法

2026-04-220
OAAI
Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection

用于肺癌生物标志物检测的微调病理基础模型的真实世界部署

2025-07-090
OAAI
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer

分子肿瘤委员会:国际肺癌研究协会的共识声明

2025-07-070
PRE
Leveraging RNA from DNA Extraction Lysate to Rescue “Insufficient” Samples for More Comprehensive Genomic Profiling in Patients with Scant Tumor Specimens

利用DNA提取裂解液中的RNA来挽救“不足”样本,以实现对肿瘤标本稀少患者更全面的基因组分析

2025-05-150
PRE
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

临床结局、基因组异质性及不同组织学亚型的尿路上皮癌的治疗考量

2025-04-260
PRE
REAL-WORLD EXPERIENCE WITH CIRCULATING TUMOR DNA IN CEREBROSPINAL FLUID IN PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMORS
2024-11-110
PRE
UTILITY OF CIRCULATING TUMOR DNA (CTDNA) FROM CEREBROSPINAL FLUID (CSF) FOR PROGNOSIS OF PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA
2024-11-110
PRE
Molecular Features Are Associated with Disease Stage in Diffuse Large B-Cell Lymphoma and Reveal Heterogeneity in Patient Outcomes

分子特征与弥漫性大B细胞淋巴瘤的疾病分期相关,并揭示了患者预后的异质性。

BLOOD
IF23.1
2024-11-050
PRE
Genomic Complexity Correlates with the Degree of Marrow Independence of Malignant Plasma Cells in the Context of Extramedullary Disease

基因组复杂性与人髓外疾病背景下恶性浆细胞的骨髓独立性程度相关。

BLOOD
IF23.1
2024-11-051
PRE
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer

ctDNA在转移性HER2-mutant肺癌患者中的最佳系统治疗和真实世界临床应用

2024-10-010
PRE
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
2024-09-170
OAAI